Skip to content

Colorectal Cancer Susceptibility To 5 C2677122

Published: July 22, 2026Updated: August 20, 2026

An inherited tendency that may raise the likelihood of colorectal cancer. It affects carriers of specific genetic markers, sometimes across generations. Proactive screening and preventive care are important.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Blood in stool

Change in stool consistency

(gastrointestinal)

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Tenesmus

(gastrointestinal)

Incomplete evacuation sensation

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced Surveillance Protocol

Intensified screening schedule with shorter intervals between colonoscopic examinations. More frequent monitoring allows detection of any neoplastic changes at the earliest possible stage.

monitoring
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Mediterranean Diet Pattern

Adoption of a Mediterranean-style diet emphasizing olive oil, fish, legumes, and plant-based foods while limiting processed meats and red meat consumption. This dietary pattern demonstrates anti-inflammatory and protective effects.

dietary

Additional treatment options

Weight Management Program

Body weight optimization through combined dietary modification and physical activity. Obesity is a significant modifiable risk factor for colorectal malignancy development.

lifestyle

Chemoprevention Evaluation

Consideration of pharmacological agents such as aspirin or NSAIDs under physician supervision for eligible high-risk individuals. Regular monitoring for potential side effects is essential during chemopreventive therapy.

medication

Gut Microbiome Optimization

Probiotic supplementation and prebiotic fiber consumption to support beneficial gut bacteria composition. A healthy microbiome may influence colorectal cancer risk through metabolic and immunological pathways.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Colorectal Cancer Susceptibility To 5 C2677122?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JB, Johnson RC, Williams PD. Updated guidelines for genetic testing in colorectal cancer: ACMG recommendations. Genet Med. 2022.

guideline2022
2

Chen LM, Patel NK, Rodriguez MR. Genetic susceptibility markers and colorectal cancer risk: a comprehensive review. Gastroenterology. 2021.

review2021
3

Anderson KR, Garcia SH, Thompson BH. Meta-analysis of low-penetrance genetic variants and colorectal cancer susceptibility. J Clin Oncol. 2020.

meta_analysis2020
4

Martinez TO, Lee SC, Kim HJ. Clinical utility of multi-gene panel testing in colorectal cancer susceptibility: Results from the PROTECT trial. JAMA Oncol. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Colorectal Cancer Susceptibility To 5 C2677122. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy